As an exception, carbapenems are recommended for patients with meningitis caused by the genus Capnocytophaga, as the combination of a beta-lactam and a beta-lactamase inhibitor does not achieve sufficiently high concentrations in the cerebrospinal fluid. Here, LACTB is linked to meningitis.